These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 26699442)

  • 1. National Lipid Association Recommendations for Patient-Centered Management of Dyslipidemia: Part 2.
    Jacobson TA; Maki KC; Orringer CE; Jones PH; Kris-Etherton P; Sikand G; La Forge R; Daniels SR; Wilson DP; Morris PB; Wild RA; Grundy SM; Daviglus M; Ferdinand KC; Vijayaraghavan K; Deedwania PC; Aberg JA; Liao KP; McKenney JM; Ross JL; Braun LT; Ito MK; Bays HE; Brown WV; Underberg JA;
    J Clin Lipidol; 2015; 9(6 Suppl):S1-122.e1. PubMed ID: 26699442
    [TBL] [Abstract][Full Text] [Related]  

  • 2. National Lipid Association recommendations for patient-centered management of dyslipidemia: part 1 - executive summary.
    Jacobson TA; Ito MK; Maki KC; Orringer CE; Bays HE; Jones PH; McKenney JM; Grundy SM; Gill EA; Wild RA; Wilson DP; Brown WV
    J Clin Lipidol; 2014; 8(5):473-88. PubMed ID: 25234560
    [TBL] [Abstract][Full Text] [Related]  

  • 3. National lipid association recommendations for patient-centered management of dyslipidemia: part 1--full report.
    Jacobson TA; Ito MK; Maki KC; Orringer CE; Bays HE; Jones PH; McKenney JM; Grundy SM; Gill EA; Wild RA; Wilson DP; Brown WV
    J Clin Lipidol; 2015; 9(2):129-69. PubMed ID: 25911072
    [TBL] [Abstract][Full Text] [Related]  

  • 4. National Lipid Association Annual Summary of Clinical Lipidology 2015.
    Bays HE; Jones PH; Brown WV; Jacobson TA;
    J Clin Lipidol; 2014; 8(6 Suppl):S1-36. PubMed ID: 25523435
    [TBL] [Abstract][Full Text] [Related]  

  • 5. National Lipid Association Annual Summary of Clinical Lipidology 2016.
    Bays HE; Jones PH; Orringer CE; Brown WV; Jacobson TA
    J Clin Lipidol; 2016; 10(1 Suppl):S1-43. PubMed ID: 26891998
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Residual dyslipidemia according to low-density lipoprotein cholesterol, non-high-density lipoprotein cholesterol, and apolipoprotein B among statin-treated US adults: National Health and Nutrition Examination Survey 2009-2010.
    Wong ND; Chuang J; Zhao Y; Rosenblit PD
    J Clin Lipidol; 2015; 9(4):525-32. PubMed ID: 26228670
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New cholesterol guidelines for the management of atherosclerotic cardiovascular disease risk: a comparison of the 2013 American College of Cardiology/American Heart Association cholesterol guidelines with the 2014 National Lipid Association recommendations for patient-centered management of dyslipidemia.
    Adhyaru BB; Jacobson TA
    Cardiol Clin; 2015 May; 33(2):181-96. PubMed ID: 25939292
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Residual Risk Reduction Initiative: a call to action to reduce residual vascular risk in patients with dyslipidemia.
    Fruchart JC; Sacks F; Hermans MP; Assmann G; Brown WV; Ceska R; Chapman MJ; Dodson PM; Fioretto P; Ginsberg HN; Kadowaki T; Lablanche JM; Marx N; Plutzky J; Reiner Z; Rosenson RS; Staels B; Stock JK; Sy R; Wanner C; Zambon A; Zimmet P
    Am J Cardiol; 2008 Nov; 102(10 Suppl):1K-34K. PubMed ID: 19068318
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of expert consensus to improve atherogenic dyslipidemia management.
    Millán Núñez-Cortés J; Pedro-Botet J; Brea-Hernando Á; Díaz-Rodríguez Á; González-Santos P; Hernández-Mijares A; Mantilla-Morató T; Pintó-Sala X; Simó R
    Rev Esp Cardiol (Engl Ed); 2014 Jan; 67(1):36-44. PubMed ID: 24774262
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dyslipidemia: management using optimal lipid-lowering therapy.
    Ito MK
    Ann Pharmacother; 2012 Oct; 46(10):1368-81. PubMed ID: 23032652
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New Cholesterol Guidelines for the Management of Atherosclerotic Cardiovascular Disease Risk: A Comparison of the 2013 American College of Cardiology/American Heart Association Cholesterol Guidelines with the 2014 National Lipid Association Recommendations for Patient-Centered Management of Dyslipidemia.
    Adhyaru BB; Jacobson TA
    Endocrinol Metab Clin North Am; 2016 Mar; 45(1):17-37. PubMed ID: 26892995
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An International Atherosclerosis Society Position Paper: global recommendations for the management of dyslipidemia.
    ; Grundy SM
    J Clin Lipidol; 2013; 7(6):561-5. PubMed ID: 24314355
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Model-based simulation to explore the cost-effectiveness of following practice guidelines for triglyceride and low-density lipoprotein cholesterol control among patients with diabetes mellitus and mixed dyslipidemia.
    Sorensen SV; Frick KD; Wade A; Simko R; Burge R
    Clin Ther; 2009 Apr; 31(4):862-79. PubMed ID: 19446159
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pitavastatin: novel effects on lipid parameters.
    Chapman MJ
    Atheroscler Suppl; 2011 Nov; 12(3):277-84. PubMed ID: 22152282
    [TBL] [Abstract][Full Text] [Related]  

  • 15. KDOQI US commentary on the 2013 KDIGO Clinical Practice Guideline for Lipid Management in CKD.
    Sarnak MJ; Bloom R; Muntner P; Rahman M; Saland JM; Wilson PW; Fried L
    Am J Kidney Dis; 2015 Mar; 65(3):354-66. PubMed ID: 25465166
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting low HDL-cholesterol to decrease residual cardiovascular risk in the managed care setting.
    Cziraky MJ; Watson KE; Talbert RL
    J Manag Care Pharm; 2008 Oct; 14(8 Suppl):S3-28; quiz S30-1. PubMed ID: 19891279
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Implementing lifestyle medicine with medication therapy management services to improve patient-centered health care.
    Lenz TL; Monaghan MS
    J Am Pharm Assoc (2003); 2011; 51(2):184-8. PubMed ID: 21382808
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting cardiovascular risk in patients with diabetes: management of dyslipidemia.
    Ali YS; Linton MF; Fazio S
    Curr Opin Endocrinol Diabetes Obes; 2008 Apr; 15(2):142-6. PubMed ID: 18316949
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence and treatment of dyslipidemia in Canadian primary care: a retrospective cohort analysis.
    Petrella RJ; Merikle E; Jones J
    Clin Ther; 2007 Apr; 29(4):742-50. PubMed ID: 17617298
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patient knowledge of coronary risk profile improves the effectiveness of dyslipidemia therapy: the CHECK-UP study: a randomized controlled trial.
    Grover SA; Lowensteyn I; Joseph L; Kaouache M; Marchand S; Coupal L; Boudreau G;
    Arch Intern Med; 2007 Nov; 167(21):2296-303. PubMed ID: 18039987
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.